Endocrine Neoplasia MEN 1& 2, Succinate Dehydrogenase (SDH) B & D
North South North West Statewide
The clinic specifically caters for patients with Multiple Endocrine Neoplasia type 1 (MEN 1), mutations of Succinate Dehydrogenase gene B and D, Paraganglioma syndromes and non-thyroid endocrine malignancies. It also undertakes investigation, management and long-term follow-up of sporadic and familial endocrine neoplasms including pre-operative investigation, post-operative planning for radioiodine therapy and hormone replacement.
Referrals accepted from state-wide, long term follow-up will undertaken in patient's home region.
All referrals should comply to referral standards and also include:
- Family history of condition
- Onset of symptoms
- Past and current investigations and treatments
- U&E Cr, eGFr, LFTs
- Ca2+, Mg2+, PO42-
To refer a patient with this condition, please see the Endocrinology clinic page for the full referral process and templates.
These are complex conditions and usually require consultant opinion prior to initiating complex investigations.
For more information please see the Tasmanian Health Pathways website.
Urgent / category 1
Hypercalcaemia (CCa 2+ > 3.0 mmol/L, ICa 2+ > 1.5 mmol/L)
Semi-urgent / category 2
Screening and routine follow-up
Red flags are clinical indicators of possible serious underlying conditions requiring further medical intervention. They may or may not indicate an emergency.
Proceed to Emergency Department (ED). Please contact ED Medical Officer in Charge:
LGH ED – Phone: (03) 6777 8302 Fax: (03) 6777 5201
MCH ED – Phone: 0409 867 492 Fax: (03) 6441 5923
NWRH ED – Phone: 0459 848 725 Fax: (03) 6464 1926
RHH ED - Phone: (03) 6166 6101 Fax: (03) 6173 0489
Urgent referrals should be accompanied by a phone call to the Consultant/Registrar to organise urgent review and the referral must be faxed.
We will endeavour to see these patients within four weeks, or sooner if clinically indicated.
We will endeavour to see these patients within 12 weeks
Next available appointment